Maryland · 2026 Regular Session · Bill

SB 778: Clinical Research Pharmacies and Clinical Trials - Permits and Ownership

Enacted Last action April 28, 2026: Approved by the Governor - Chapter 206

Plain-language summary

SB 778 is a bill introduced in the Maryland Senate on February 6, 2026. According to its official title, it concerns: Clinical Research Pharmacies and Clinical Trials - Permits and Ownership. Primary sponsor: Brian Feldman (Democratic). Most recent recorded action (April 28, 2026): Approved by the Governor - Chapter 206.

Sponsors

Primary sponsor: Brian Feldman (Democratic).